These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21679198)

  • 1. Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device.
    Sims DB; Rosner G; Uriel N; González-Costello J; Ehlert FA; Jorde UP
    Pacing Clin Electrophysiol; 2012 May; 35(5):e144-8. PubMed ID: 21679198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
    Raasch H; Jensen BC; Chang PP; Mounsey JP; Gehi AK; Chung EH; Sheridan BC; Bowen A; Katz JN
    Am Heart J; 2012 Sep; 164(3):373-8. PubMed ID: 22980304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation.
    Salzberg SP; Lachat ML; Zünd G; Turina MI
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):444-6. PubMed ID: 15296915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained ventricular fibrillation in an alert patient: preserved hemodynamics with a left ventricular assist device.
    Patel P; Williams JG; Brice JH
    Prehosp Emerg Care; 2011; 15(4):533-6. PubMed ID: 21806468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading.
    Garcia S; Kandar F; Boyle A; Colvin-Adams M; Lliao K; Joyce L; John R
    J Heart Lung Transplant; 2008 Mar; 27(3):261-7. PubMed ID: 18342746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placement of a continuous-flow ventricular assist device in the failing ventricle of an adult patient with complex cyanotic congenital heart disease.
    Morris CD; Gregoric ID; Cooley DA; Cohn WE; Loyalka P; Frazier OH
    Heart Surg Forum; 2008; 11(3):E143-4. PubMed ID: 18583283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
    Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
    J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent orthostatic syncope due to left atrial and left ventricular collapse after a continuous-flow left ventricular assist device implantation.
    Chandra A; Pradhan R; Kim FY; Frisch DR; Bogar LJ; Bonita R; Cavarocchi NC; Greenspon AJ; Hirose H; Pitcher HT; Rubin S; Mather PJ
    J Heart Lung Transplant; 2013 Jan; 32(1):129-33. PubMed ID: 23260713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of newly developed atrial fibrillation complicated with longstanding ventricular fibrillation during left ventricular assist device support: A case report.
    Bujo C; Amiya E; Hatano M; Tsuji M; Maki H; Hosoya Y; Fujii E; Kamon T; Kojima T; Nawata K; Kinoshita O; Kimura M; Ono M; Komuro I
    BMC Cardiovasc Disord; 2019 Jun; 19(1):151. PubMed ID: 31226943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices.
    Thohan V; Stetson SJ; Nagueh SF; Rivas-Gotz C; Koerner MM; Lafuente JA; Loebe M; Noon GP; Torre-Amione G
    J Heart Lung Transplant; 2005 May; 24(5):566-75. PubMed ID: 15896754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular fibrillation in an ambulatory patient supported by a left ventricular assist device: highlighting the ICD controversy.
    Boilson BA; Durham LA; Park SJ
    ASAIO J; 2012; 58(2):170-3. PubMed ID: 22370689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved left ventricular unloading and circulatory support with synchronized pulsatile left ventricular assistance compared with continuous-flow left ventricular assistance in an acute porcine left ventricular failure model.
    Letsou GV; Pate TD; Gohean JR; Kurusz M; Longoria RG; Kaiser L; Smalling RW
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1181-8. PubMed ID: 20546799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential exercise performance on ventricular assist device support.
    Simon MA; Kormos RL; Gorcsan J; Dohi K; Winowich S; Stanford E; Carozza L; Murali S
    J Heart Lung Transplant; 2005 Oct; 24(10):1506-12. PubMed ID: 16210122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
    Petrucci RJ; Rogers JG; Blue L; Gallagher C; Russell SD; Dordunoo D; Jaski BE; Chillcott S; Sun B; Yanssens TL; Tatooles A; Koundakjian L; Farrar DJ; Slaughter MS
    J Heart Lung Transplant; 2012 Jan; 31(1):27-36. PubMed ID: 22153550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.